Recital 74, Decision_act (EU) 2002/742

In forcesince 5 Dec 2001

A few weeks after its purchase of Pfizer's citric acid business, ADM arranged several bilateral meetings with other citric acid manufacturers, ostensibly for the purpose of introducing itself to its competitors.